UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 OR 15(d)
of The
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
| (Address of principal executive offices) | (Zip Code) |
Registrant's telephone number, including area
code: (
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name
of each exchange on which registered | ||
| OTC Markets |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 2.01 Completion of Acquisition or Disposition of Assets.
As previously approved by the stockholders of Axcella Health Inc. (“Axcella”) at its special meeting of its stockholders on December 4, 2023, on December 5, 2023 Axcella completed the transfer of all or substantially all of Axcella’s assets to Axcella (assignment for the benefit of creditors), LLC, a Delaware limited liability company, through an assignment for the benefit of creditors under Delaware law.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Axcella Health Inc. | ||
| Date: December 19, 2023 | By: | /s/ Craig R. Jalbert |
| Name: | /s/ Craig R. Jalbert | |
| Title: | President, Chief Executive Officer and Sole Director | |
Cover |
Dec. 05, 2023 |
|---|---|
| Cover [Abstract] | |
| Document Type | 8-K |
| Amendment Flag | false |
| Document Period End Date | Dec. 05, 2023 |
| Entity File Number | 001-38901 |
| Entity Registrant Name | AXCELLA HEALTH INC. |
| Entity Central Index Key | 0001633070 |
| Entity Tax Identification Number | 26-3321056 |
| Entity Incorporation, State or Country Code | DE |
| Entity Address, Address Line One | 124 Washington Street, Suite 101 |
| Entity Address, City or Town | Foxboro |
| Entity Address, State or Province | MA |
| Entity Address, Postal Zip Code | 02035 |
| City Area Code | 857 |
| Local Phone Number | 320-2200 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Common Stock, $0.001 Par Value |
| Trading Symbol | AXLA |
| Entity Emerging Growth Company | true |
| Elected Not To Use the Extended Transition Period | false |